Is it time to include CT "reverse halo sign" and qPCR targeting mucorales in serum to EORTC-MSG criteria for the diagnosis of pulmonary mucormycosis in leukemia patients?

31Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In 23 leukemia patients with proven (n = 17) or possible (n = 6) pulmonary mucormycosis (PM), the presence of reversed halo sign on computed tomography was strongly associated with the positivity of quantitative polymerase chain reaction assays targeting Mucorales in the serum, confirming the value of these two tools for the diagnosis of PM in this setting.

Cite

CITATION STYLE

APA

Caillot, D., Valot, S., Lafon, I., Basmaciyan, L., Chretien, M. L., Sautour, M., … Dalle, F. (2016). Is it time to include CT “reverse halo sign” and qPCR targeting mucorales in serum to EORTC-MSG criteria for the diagnosis of pulmonary mucormycosis in leukemia patients? Open Forum Infectious Diseases, 3(4). https://doi.org/10.1093/ofid/ofw190

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free